BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CANT1, ENSG00000171302, 124583, Q8WVQ1, SHAPY, SCAN-1 AND Treatment
15 results:

  • 1. Pan-cancer analysis predicts cant1 as a potential prognostic, immunologic biomarker.
    Yang W; Liu Z; Liu T
    Cell Signal; 2024 May; 117():111107. PubMed ID: 38369265
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Predictive value of
    Tang S; Zhang Y; Li Y; Zhang Y; Xu Y; Ding H; Chen Y; Ren P; Ye H; Fu S; Lin S
    Front Immunol; 2023; 14():1034416. PubMed ID: 36860861
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Calcium-activated nucleotides 1 (cant1)-driven nuclear factor-k-gene binding (NF-ĸB) signaling pathway facilitates the lung cancer progression.
    Gao F; Hu X; Liu W; Wu H; Mu Y; Zhao Y
    Bioengineered; 2022 Feb; 13(2):3183-3193. PubMed ID: 35068336
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [A Case of Primary Liposarcoma of Pancreas Difficult to Diagnose Preoperatively].
    Suzuki A; Matsui H; Tokumitsu Y; Shindou Y; Matsukuma S; Nakajima M; Tomochika S; Yoshida S; Iida M; Suzuki N; Takeda S; Yoshino S; Hazama S; Nagano H
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):1921-1923. PubMed ID: 33468873
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Response evaluation after immunotherapy in NSCLC: Early response assessment using FDG PET/CT.
    Park S; Lee Y; Kim TS; Kim SK; Han JY
    Medicine (Baltimore); 2020 Dec; 99(51):e23815. PubMed ID: 33371161
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The efficiency of
    Tao X; Li N; Wu N; He J; Ying J; Gao S; Wang S; Wang J; Wang Z; Ling Y; Tang W; Zhang Z
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1209-1219. PubMed ID: 32043180
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case.
    Stenman A; Hellgren LS; Jatta K; Hysek M; Zemmler M; Altena R; Nilsson IL; Bränström R; Zedenius J; Juhlin CC
    Endocr Pathol; 2020 Mar; 31(1):77-83. PubMed ID: 32016808
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [A case of advanced pancreas cancer successfully treated by using combined modality therapy].
    Sunose Y; Takeyoshi I; Hirai K; Igarashi T; Takahashi K; Yamazaki H; Tanaka K; Takahashi N; Tsukagoshi H; Ogawa H; Yoshinari D; Yokoo H
    Gan To Kagaku Ryoho; 2015 Feb; 42(2):241-4. PubMed ID: 25743148
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Reproducibility of FDG PET based metabolic tumor volume measurements and of their FDG distribution within.
    Kruse V; Mees G; Maes A; D'Asseler Y; Borms M; Cocquyt V; Van De Wiele C
    Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):462-8. PubMed ID: 24695005
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Radiotherapy for nasopharyngeal carcinoma and combined capecitabine and nimotuzumab treatment for lung metastases in a liver transplantation recipient: a case experience of sustained complete response.
    Yan S; Jiang X; Yang J; Yan D; Wang YX
    Cancer Biother Radiopharm; 2012 Oct; 27(8):519-23. PubMed ID: 22834655
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer.
    Everitt S; Herschtal A; Callahan J; Plumridge N; Ball D; Kron T; Schneider-Kolsky M; Binns D; Hicks RJ; MacManus M
    Cancer; 2010 Nov; 116(21):5030-7. PubMed ID: 20623786
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Radiofrequency ablation of primary and metastatic lung tumors: preliminary experience with a single center device.
    Laganà D; Carrafiello G; Mangini M; Boni L; Dionigi G; Fusi MC; Cinquepalmi L; Rovera F; Cuffari S; Fugazzola C
    Surg Endosc; 2006 Aug; 20(8):1262-7. PubMed ID: 16858532
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Small cell carcinoma of the esophagus responding to fourth-line chemotherapy with weekly paclitaxel.
    Matsuoka M; Boku N; Yoshino T; Hironaka S; Onozawa Y; Fukutomi A; Zenda S; Yamazaki K; Yasui H; Hasuike N; Inui T; Yamaguchi Y; Ono H; Kamata M
    Int J Clin Oncol; 2005 Dec; 10(6):429-32. PubMed ID: 16369748
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A phase II study of temozolomide in hormone-refractory prostate cancer.
    van Brussel JP; Busstra MB; Lang MS; Catsburg T; Schröder FH; Mickisch GH
    Cancer Chemother Pharmacol; 2000; 45(6):509-12. PubMed ID: 10854140
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma.
    Lin JD; Kao PF; Chao TC
    Br J Radiol; 1998 Mar; 71(843):307-13. PubMed ID: 9616241
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.